Our findings uncover the MISP‐MST1/2‐SLC7A11 axis as a key mediator in lung cancer progression and provide support for the connection between MISP and ferroptosis, offering significant therapeutic implications for YAP‐driven tumors. The gene discussed is MISP; the disease is lung carcinoma.